Biotron Limited (ASX: BIT) - Share Price

- Current share price for BIT : $0.002

Biotron Limited (BIT), an ASX-listed company, is a clinical stage publicly listed Australian Biotechnology Company based in Sydney, Australia. The company is developing and commercialising a novel small molecule approach that has the potential to treat a number of serious viral diseases. The technology targets viroporin proteins, which are key to enabling the pathogenicity of a number of viruses including hepatitis C, HIV-1, Dengue, Zika, Influenza and Respiratory Syncytial Virus (RSV).

BIT General Information ⁺

ASX Code	BIT
Website	http://www.biotron.com.au
Industry/Sector	Biotechnology
Market Cap ($M)	5
BIT Share Price	$0.002
Day High	$0.000
Day Low	$0.000
Last Close	$0.002
BIT Share Price Movement	- ( No change )

Prices as at 16:40, 28 Jul 2026

⁺Security prices are delayed by at least 20 minutes and are indicative only.

Biotron Limited (BIT) Upcoming Dividends & Yields

Distribution Type	Dividend	Franking	Ex-dividend date	Payment date	Current Price⁺	Price 7D Avg	Dividend Yield

See all dividends from Biotron Limited (BIT) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

Biotron Limited (BIT) price-sensitive announcements

BIT - Quarterly Activities/Appendix 4C Cash Flow Report

During the quarter ended 30 June 2026, Biotron Limited reported on several financial and o

Biotron Limited (BIT)
21 Jul 2026 | 10:46 AM

BIT - Sedarex First Milestone Met

Biotron Limited announced that the first milestone for the acquisition of Sedarex has been

Biotron Limited (BIT)
13 Jul 2026 | 11:24 AM

BIT - $525K R&D Rebate Received

Biotron Limited announced the receipt of a $525,869 R&D Tax Incentive rebate for the 2024/

Biotron Limited (BIT)
4 Jun 2026 | 9:13 AM

BIT - Quarterly Activities/Appendix 4C Cash Flow Report

Biotron Limited's quarterly activities report for the period ending 31 March 2026 outlines

Biotron Limited (BIT)
29 Apr 2026 | 10:01 AM

Biotron Limited (BIT) Recent ASX Announcements

Company	Sector	Market Cap ($m)	Headline	Release date/time⁺	Price at release⁺	Current price⁺	Gain/Loss
Biotron Limited (BIT) ORDINARY FULLY PAID	Health Care	$6	Quarterly Activities/Appendix 4C Cash Flow Report	21 Jul 2026 10:46AM	$0.002	$0.002	fallen by 0%
Biotron Limited (BIT) ORDINARY FULLY PAID	Health Care	$6	Change of Director's Interest Notice	15 Jul 2026 4:48PM	$0.002	$0.002	fallen by 0%
Biotron Limited (BIT) ORDINARY FULLY PAID	Health Care	$6	Application for quotation of securities - BIT	13 Jul 2026 11:30AM	$0.003	$0.002	fallen by 20%
Biotron Limited (BIT) ORDINARY FULLY PAID	Health Care	$6	Sedarex First Milestone Met	13 Jul 2026 11:24AM	$0.003	$0.002	fallen by 20%
Biotron Limited (BIT) ORDINARY FULLY PAID	Health Care	$6	Application for quotation of securities - BIT	17 Jun 2026 12:51PM	$0.002	$0.002	fallen by 0%
Biotron Limited (BIT) ORDINARY FULLY PAID	Health Care	$6	$525K R&D Rebate Received	4 Jun 2026 9:13AM	$0.003	$0.002	fallen by 20%

BIT Financial Summary

Year to Jun	NPAT	EPS	EPS chg (%)	Yield (%)	Franking (%)
2025A	-$0.32	N2	-90.90%	0.00%	0.0%
2024A	-$3.44	-$0.30	-10.80%	0.00%	0.0%
2023A	-$3.49	-$0.40	8.80%	0.00%	0.0%

BIT Peer Comparison

Company	Mkt Cap	EPS Growth (%)			P/E (%)			Dividend Yield (%)
Company	Mkt Cap	2023 A	2024 A	2025 A	2023 A	2024 A	2025 A	2023 A	2024 A	2025 A
Biotron Limited (BIT)	$6M	-0.9091	0.0000	0.0000	0.0000	0.0000	0.0000	0.00%	0.00%	0.00%
CSL Limited (CSL)	$54,701M	0.1108	-0.1184	0.0168	12.2479	13.8930	13.6638	3.90%	3.20%	3.32%
Clinuvel Pharmaceuticals Limited (CUV)	$507M	0.0287	0.0000	0.0000	14.0111	0.0000	0.0000	0.50%	0.00%	0.00%
Mesoblast Limited (MSB)	$2,883M	0.0301	0.0000	0.0000	0.0000	0.0000	0.0000	0.00%	0.00%	0.00%
Telix Pharmaceuticals Limited (TLX)	$4,981M	-1.3893	0.0000	-0.4227	0.0000	161.8102	280.3059	0.00%	0.00%	0.00%

BIT Market Comparison

	Earnings	P/E Ratio	P/B Ratio	P/E Growth
Company	0.00	0.00	5.00	0.00
Market	0.30	12.80	1.13	0.58
Sector	0.43	31.10	2.43	2.46

BIT Directors

Name	Position	Start Date
Dr Michelle Miller	Managing Director	21 Jun 2002
Mr Michael James Medway	Non-Executive Director	16 Jul 2025
Mr Graeme Wald	Non-Executive Director	30 Mar 2026
Dr Paul Alexander Kasian	Non-Executive Director, Non-Executive Chairman	23 Dec 2025

Biotron Limited (BIT) Changes in Directors' Interest & Trades

Date of change	Director	Buy/Sell	Security Type	Qty	Trade Price	Value
13 Jul 2026	WALD, Graeme	Buy	Indirect Shares	16,276,333	$0.003	$48,828.999
13 Jul 2026	KASIAN, Paul	Buy	Indirect Shares	12,189,000	$0.003	$36,567.000
19 Dec 2025	MILLER, Michelle	Issued	Indirect Shares	1,200,000	$0.003	$3,600.000

See all changes in directors' interest & trades for Biotron Limited (BIT) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

BIT Management

Name	Position
Marcelo Mora	Company Secretary

BIT Calendar of Events

Date	Event
25 February 2027	Report (Interim)
16 October 2026	Report (Annual)
26 August 2026	Report (Annual)
26 August 2026	Report (Prelim)

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.

What our members say about us